Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2025)

Drugs Made In America Acquisition (DMII) posted quarterly Total Liabilities of $17.8 million for Q4 2025, up 6886.68% year-over-year from $254783.0 in Q4 2024, and down 2.07% quarter-over-quarter from $18.2 million in Q3 2025.

Drugs Made In America Acquisition (DMII) Total Liabilities (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Total Liabilities for 2 consecutive years, with $17.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Liabilities rose 6886.68% year-over-year to $17.8 million; the TTM figure through Dec 2025 stood at $17.8 million (up 6886.68% YoY), while the FY2025 annual figure was $17.8 million, up 6886.68% from the prior year.
  • Total Liabilities declined to $17.8 million in Q4 2025 per DMII's latest filing, from $18.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $18.2 million in Q3 2025 and bottomed at $254783.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - 11.23 Mn
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 18.14 Mn
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 385,932.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 16.42 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - 20,057.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - 31.85 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 34.24 Mn
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - 9.60 Mn
9 Berto Acquisition 313.96 Mn 313.81 Mn - 14.12 Mn
10 New Providence Acquisition Corp. III 313.81 Mn 313.81 Mn - 14.19 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.80 Mn
Sep 30, 2025 18.18 Mn
Dec 31, 2024 254,783.00